OTR-AC vs Wolverine — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
OTR-AC is the common name for oral high-dose BPC-157 acetate. The peptide sequence (GEPPPGKPADDAGLV) is identical to injectable BPC-157 but is dosed at 2–5 mg orally rather than 250–500 µg subcutaneously to compensate for GI degradation and first-pass metabolism. The oral route p...
Calculate OTR-AC dose →Wolverine is a research peptide blend combining BPC-157 (5 mg) and TB-500 (5 mg) in a single vial. BPC-157 drives localized tissue repair and gut protection via angiogenesis; TB-500 promotes systemic cell migration and actin remodeling. Together they target overlapping healing pa...
Calculate Wolverine dose →| Parameter | OTR-AC | Wolverine |
|---|---|---|
| Category | Healing & Recovery | Healing & Recovery |
| Research | Preclinical | Research Blend |
| Half-Life | 4–6 hours (estimated, oral) | BPC-157: 4-6 h; TB-500: ~5 days |
| Typical Dose | 2–5 mg | 500-1,000 µg |
| Frequency | Once daily | 2-3x per week |
| Route | Oral | Subcutaneous |
| FDA Status | Not Approved | Not Approved |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.